Alpha 1-antitrypsin deficiency: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]]
'''For patient information, click [[Alpha 1-antitrypsin deficiency (patient information)|here]]
{{DiseaseDisorder infobox |
{{DiseaseDisorder infobox |
Line 9: Line 10:
   DiseasesDB    = 434 |
   DiseasesDB    = 434 |
   MedlinePlus    = 000120 |
   MedlinePlus    = 000120 |
  eMedicineSubj  = |
  eMedicineTopic = |
}}
}}
{{Alpha 1-antitrypsin deficiency}}
{{Alpha 1-antitrypsin deficiency}}
Line 37: Line 36:
[[Alpha 1-antitrypsin deficiency primary prevention|Primary Prevention]] | [[Alpha 1-antitrypsin deficiency secondary prevention|Secondary Prevention]] | [[Alpha 1-antitrypsin deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]]
[[Alpha 1-antitrypsin deficiency primary prevention|Primary Prevention]] | [[Alpha 1-antitrypsin deficiency secondary prevention|Secondary Prevention]] | [[Alpha 1-antitrypsin deficiency cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Alpha 1-antitrypsin deficiency future or investigational therapies|Future or Investigational Therapies]]


==See Also==
==Related Chapters==
* [[COPD]]
* [[COPD]]
* [[Emphysema]]
* [[Emphysema]]

Revision as of 13:11, 24 September 2012

For patient information, click here Template:DiseaseDisorder infobox

Alpha 1-antitrypsin deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alpha 1-antitrypsin deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alpha 1-antitrypsin deficiency On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alpha 1-antitrypsin deficiency

CDC on Alpha 1-antitrypsin deficiency

Alpha 1-antitrypsin deficiency in the news

Blogs on Alpha 1-antitrypsin deficiency

Directions to Hospitals Treating Alpha 1-antitrypsin deficiency

Risk calculators and risk factors for Alpha 1-antitrypsin deficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Historical Perspective

Pathophysiology

Differentiating Alpha 1-antitrypsin deficiency from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical: Medical Therapy

Surgical: Surgery

Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Related Chapters

Template:Endocrine, nutritional and metabolic pathology


Template:WikiDoc Sources